Sonenberg, Nahum
$1,500,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- April 1, 2019 – March 31, 2023
- Reference
- cihr-irsc:236-2019-2020-Q1-00365
Published purpose
The SU2C Canada – Metastatic Breast Cancer Dream Team funding opportunity is expected to focus the efforts of the Canadian research community on accelerating the pace of ground-breaking translational research on critical problems in metastatic breast cancer. The successful Dream Team: Will develop a translational cancer research project that addresses critical problems in metastatic cancer patient care, including prevention strategies for those at risk and gaining a mechanistic understanding of metastatic progression. Will design and carry out projects that accelerate the application of preventative, diagnostic or therapeutic approaches to the clinic. Will include plans describing how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.